To Ensure a Rapid Entry to Market with its Revolutionary Instant COVID-19 Testing Platform, Blink Science Inc. Adds to its Technology Team

Blink Science adds Chuck Harvey as CIO and Emmanuel Diserbeau as Head of Blink Science IT Architecture and Engineering.

ATLANTA, Jan. 26, 2021 /PRNewswire/ —Blink Science, Inc. a company dedicated to revolutionizing global point-of-care medical diagnostics, has added two key individuals to their leadership team.

Chuck Harvey joins Blink Science as Chief Information Officer. With more than 30 years of IT and technology experience, Harvey dedicated the past two decades to leading IT and engineering functions for Boost Mobile, Cricket Wireless and Nuvectra Medical as the CIO/CTO. As CIO for medical device start-up Nuvectra Medical, Harvey created and managed IT, helping make them an independently managed, publicly traded company. His experience includes leading the delivery of all enterprise platforms, leading engineering efforts focused on driving improved patient outcomes, and building and managing the cyber-security strategies to enable the company to operate in the highly regulated medical device industry, including HIPAA readiness. Chuck defined and deployed the organizational strategy for the company’s technology function, hired the team to deliver across his IT services model, and built award-winning mobile, web and cloud-based technology products.

Emmanuel Diserbeau joins Blink Science as Head of IT Architecture and Engineering. Emmanuel brings more than 15 years of advanced technical expertise in technology architecture and engineering. His background includes building award-winning technology products across mobile, web and cloud deployments. 

To Ensure a Rapid Entry to Market with its Revolutionary Instant COVID-19 Testing Platform, Blink Science, Inc. adds CIO

Emmanuel is passionate about technology and has been innovating technology solutions in the medical device space for the past five years. He is an expert in designing, building and deploying software and hardware solutions that have driven improved patient outcomes. Emmanuel will lead solutions architecture and engineering across the Blink Science technology stack. He will work closely with our technology teams to build solutions across mobile, web and cloud to enable Blink Science to scale quickly with high-availability and high-performing architectures.

Eric Doherty, Blink Science President, stated, “I am excited to welcome Chuck Harvey and Emmanuel Diserbeau to our innovative team. Their contributions will factor greatly in our ability to bring our incredible new diagnostic testing technology to market quickly, along with providing the strong architecture needed for blinkPASSPORT and blinkVerify to the public and corporate sectors.  We are looking to be a part of The Commons Project coalition, and the Vaccination Credential Initiative to help develop the needed standards within the healthcare passport programming.  Working with companies like Oracle, Microsoft, IBM Watson, and the Mayo Clinic, we will have the end-product these healthcare passports need: instant, reliable, testing results.” 

For investors interested in being part of the revolutionary technology, Blink Science welcomes conversations with corporations about funding their high-tech, low-cost point-of-care diagnostic tools. These tools have immediate application for COVID-19 but other forthcoming possible applications, too, including rapid testing for heart attacks and concussions as well as oncology diagnostics. Blink Science is in the process of pursuing FDA Emergency Use Authorization for blinkTEST, a handheld Point of Care (POC) diagnostic testing platform that allows for rapid, sensitive detection and quantification of SARS-CoV-2 from a small saliva sample.

About Blink Science
At Blink Science, we endeavor to bring high-tech, low-cost diagnostic tools to the global medical community. Our goal is to revolutionize point-of-care (POC) testing to ensure safe, fast, precise diagnosis and treatment for acute and chronic conditions that impact people throughout the world. This revolutionary test is set to change the world of diagnostic testing.

Test. Blink. Go.

https://www.blinkscience.com/

Twitter @blinksci 
LinkedIn @blinksci

Media Contact:
Sandra McCollum
CEO/Brand Manager, Dash Brand Management
sandra@dashbrandmanagement.com 
(970) 217-6310

Press Release: https://www.prnewswire.com/news-releases/to-ensure-a-rapid-entry-to-market-with-its-revolutionary-instant-covid-19-testing-platform-blink-science-inc-adds-to-its-technology-team-301214597.html

New Blink Science President to Lead Development of the World’s First Instant COVID POC Diagnostic Testing Device and Electronic Medical Passport

ATLANTA, Jan. 19, 2021 /PRNewswire/ — Blink Science, Inc., creator of instant diagnostic tools and innovative medical passport systems, announces the appointment of Eric Doherty as the company’s new president.  

Doherty joins Blink Science with nearly 30 years of healthcare executive leadership experience. He has held senior-level sales operations and marketing roles at leading healthcare companies such as GlaxoSmithKline, Abbott Laboratories, Uvanta Pharmacy Systems, AstraZeneca, and GLOCK International.

“I couldn’t be more passionate about Blink Science’s mission to bring high-quality, low-cost diagnostic testing to everyone,” Doherty said. “And our medical passport system, blinkPASSPORT, will keep life and commerce going as well as put people’s medical data in their own hands. We’ve got an exceptional team and culture here, and I’m proud to lead it.”

Doherty is passionate about Blink Science’s mission to bring high-quality, low-cost diagnostic testing to everyone.

Doherty continued, “From a global perspective, we are working with the world’s largest healthcare distributors and the world’s largest shipping and logistics organizations to ensure that once we receive an EUA for our device, we can ship it to the places that need it, immediately.  ZoomInfo has been a huge help in disseminating information about what Blink Science is working on, so we can help end this Pandemic.”

“Eric has just the right background and exceptional leadership skills to quickly make Blink Science a household name worldwide,” said Billy Meadow, Blink Science’s founder, CEO and board chair. “Our testing technology and data platforms will measurably improve the quality of life for billions of people—not just related to COVID but for many infectious diseases as well as other conditions where instant, portable diagnosis is critical. Eric will bring us to market in 2021.” 

Doherty holds MBA’s from both St. Louis University and Washington University in International Marketing and Management, and Global Operational Leadership Certification from St. Louis University.

About Blink Science
At Blink Science, we endeavor to bring high-tech, low-cost diagnostic tools to the global medical community. Our goal is to revolutionize point-of-care testing to ensure safe, fast, precise diagnosis and treatment for acute and chronic conditions that impact people throughout the world.

Test. Blink. Done.™

www.blinkscience.com

Twitter @blinksci 
LinkedIn @blinksci

Connect with Eric Doherty
Twitter @presblinksci 
LinkedIn @ericdoherty

CONTACT: Carlo De La Mata, carlodelamata@blinkscience.com

Press Release: https://www.prnewswire.com/news-releases/blink-science-inc-names-eric-doherty-president-301210825.html